Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
暂无分享,去创建一个
Giovanni Rizzo | Pietro Cortelli | Claudia Testa | Caterina Tonon | Raffaele Lodi | Sabina Capellari | B. Barbiroli | D. Manners | G. Rizzo | R. Lodi | P. Cortelli | C. Testa | C. Tonon | E. Malucelli | P. Martinelli | P. Montagna | S. Capellari | Piero Parchi | C. Scaglione | Piero Parchi | Pasquale Montagna | Paolo Martinelli | David Manners | Emil Malucelli | Bruno Barbiroli | Cesa Scaglione
[1] Christian Kremser,et al. Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study , 2006, NeuroImage.
[2] W. Poewe,et al. Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[3] C Kremser,et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.
[4] T. Mizutani,et al. Imaging of corticobasal degeneration syndrome , 2007, Neuroradiology.
[5] Y. Takanashi,et al. Discrepancy between clinical and pathological diagnoses of CBD and PSP , 2005, Journal of Neurology.
[6] I Litvan,et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[7] Francesco Fera,et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.
[8] H. Mizusawa,et al. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET , 2001, Nuclear medicine communications.
[9] D W Dickson,et al. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.
[10] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[11] Johannes Dichgans,et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration , 2004, NeuroImage.
[12] A. Righini,et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. , 2004, AJNR. American journal of neuroradiology.
[13] R. Hauser,et al. Magnetic Resonance Imaging of Corticobasal Degeneration , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[14] S. Brockstedt,et al. Tracking the neurodegeneration of parkinsonian disorders – a pilot study , 2007, Neuroradiology.
[15] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[16] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[17] Joseph James Duffy,et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.
[18] E. Kunesch,et al. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes , 2004, Movement disorders : official journal of the Movement Disorder Society.
[19] D. Dickson,et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.
[20] B. Choe,et al. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis , 2005, Neuroscience Letters.
[21] H. Fukuyama,et al. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. , 1998, Archives of neurology.
[22] D. Radice,et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.
[23] E. Tolosa,et al. Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting , 2005, Movement disorders : official journal of the Movement Disorder Society.
[24] Klaus Seppi,et al. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism , 2005, Current opinion in neurology.
[25] Dennis W Dickson,et al. Progressive Supranuclear Palsy: Pathology and Genetics , 2007, Brain pathology.
[26] G J Barker,et al. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI , 2006, Neurology.
[27] P. Ashby,et al. Cortical‐basal ganglionic degeneration , 1990, Neurology.
[28] K. Arai. MRI of progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy , 2006, Journal of Neurology.
[29] Clifford R Jack,et al. Rates of cerebral atrophy differ in different degenerative pathologies. , 2006, Brain : a journal of neurology.
[30] L. Defebvre,et al. Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: The utility of factorial discriminant analysis , 2005, Movement disorders : official journal of the Movement Disorder Society.
[31] A. Kastrup,et al. Penguins and hummingbirds: Midbrain atrophy in progressive supranuclear palsy , 2006, Neurology.
[32] Irene Litvan,et al. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.
[33] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[34] Christian Kremser,et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.
[35] B. Barbiroli,et al. Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease , 1999, Movement Disorders.
[36] Aldo Quattrone,et al. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[37] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[38] A. Hillis,et al. Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel , 2003, Annals of neurology.
[39] J. Winn,et al. Brain , 1878, The Lancet.
[40] A. Lees,et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.
[41] B. Barbiroli,et al. Diffusion‐weighted imaging study of patients with essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.
[42] H. Tachibana,et al. Cortical‐basal ganglionic degeneration , 1995, Neurology.
[43] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[44] B. Miller,et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. , 2005, AJNR. American journal of neuroradiology.
[45] G. Abbruzzese,et al. Impairment of transcallosal inhibition in patients with corticobasal degeneration , 2003, Clinical Neurophysiology.
[46] Andrew J Lees,et al. Diffusion‐weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple‐system atrophy from progressive supranuclear palsy , 2007, Movement disorders : official journal of the Movement Disorder Society.
[47] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[48] C Kremser,et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.
[49] B. Boeve,et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome , 2005, Movement disorders : official journal of the Movement Disorder Society.
[50] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[51] M. Weiger,et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics , 2004, Neurology.
[52] F. Tison,et al. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.
[53] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[54] C. Jack,et al. Voxel-based morphometry in autopsy proven PSP and CBD , 2008, Neurobiology of Aging.
[55] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[56] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[57] Mario Mascalchi,et al. Diffusion-weighted MR of the brain: methodology and clinical application. , 2005, La Radiologia medica.
[58] J. Jankovic,et al. Parkinson's Disease and Movement Disorders , 1988 .
[59] C. Jack,et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. , 2004, Archives of neurology.
[60] Maria Luisa Gorno-Tempini,et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. , 2006, Archives of neurology.
[61] K. Ishii. Clinical application of positron emission tomography for diagnosis of dementia , 2002, Annals of nuclear medicine.